• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

New Delhi: Ranbaxy Laboratories has received authorisation from Ministry of Health and Labour Welfare of Japan for marketing the generic version of amlodipine tablets of 2.5mg and 5mg.

Amlodipine is the first independent product approval received by company in Japan and also has the distinction of being the first product developed by any foreign generic pharmaceutical company outside Japan and subsequently being granted approval by the Japanese Government, the company said in a release.

The molecule has a market size of around $2 billion and is the largest molecule that has gone off patent in Japan and represents the biggest generic opportunity so far in the Japanese generic market, the release added. — Our Bureau

More Stories on : Announcements | Pharmaceuticals | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Ranbaxy drug gets Japan’s nod

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line